Evolent Health reports developments tied to its healthcare services business for people with complex conditions. Company news commonly covers operating and financial results, customer activity with health plans and providers, and the Performance Suite contract model used in its specialty care operations.
Recurring updates also include Evolent's complex specialty care focus in oncology, cardiology and musculoskeletal conditions, management participation in healthcare investor conferences, leadership appointments, board and compensation matters, and equity-award disclosures under NYSE rules.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Evolent Health has nominated Richard Jelinek for election to its Board of Directors at the upcoming annual meeting scheduled for June 8, 2023. Jelinek, who is a managing partner at Czech One Capital Partners, has extensive experience in the health care sector, including executive roles at Aetna and CVS Health. His appointment coincides with the departure of current board member David Farner and former Chairman Frank Williams, both set to leave the board in June 2023. Evolent's leadership believes Jelinek's expertise will enhance the board's perspectives and support the company’s mission in value-based specialty care. The board expressed gratitude for the contributions of Farner and Williams, emphasizing the importance of evolving governance.
Summary not available.
Evolent Health (NYSE: EVH) announced on March 29, 2023, an agreement with Centene Corporation (NYSE: CNC) to enhance its Technology and Services solution for oncology care. This partnership will extend Evolent's oncology services to Centene’s Medicare Advantage members across the nation, deepening their existing collaboration in the specialty care market. Both companies aim to optimize oncology outcomes while managing costs effectively. Evolent's established platform, backed by scientific advisory boards, focuses on clinical quality and financial accountability, ensuring improved care delivery for patients.
Evolent Health (NYSE: EVH) announced participation in several upcoming investor conferences. Chief Financial Officer John Johnson and Vice President of Investor Relations Seth Frank will represent the company. Details include:
- March 7, 2023: Cowen 43rd Annual Healthcare Conference in Boston at 10:30 a.m. ET.
- March 13, 2023: Annual Jefferies Value-Based Healthcare Summit in Miami Beach (no webcast).
- March 14, 2023: Barclays Global Healthcare Conference in Miami Beach at 3:35 p.m. ET.
Webcast recordings will be available on the investor relations section of Evolent's website. Evolent Health focuses on clinical and administrative solutions that improve health care affordability and accessibility.